Haukeland University Hospital: clinical-trial pipeline
Haukeland University Hospital is the sponsor of 283 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 83 are not yet finished and 1 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 215 |
| Phase 2 | 30 |
| Phase 3 | 11 |
| Phase 4 | 10 |
| Phase 1/2 | 6 |
| Phase 1 | 5 |
| Phase 2/3 | 4 |
| Early phase 1 | 2 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 126 |
| Unknown | 48 |
| Recruiting | 46 |
| Active, not recruiting | 27 |
| Terminated | 20 |
| Not yet recruiting | 10 |
| Withdrawn or not authorised | 6 |
Condition areas
| Area | Trials |
|---|---|
| Psychiatry and mental health | 37 |
| Neurology | 34 |
| Cardiovascular | 33 |
| Oncology | 33 |
| Rare and genetic diseases | 31 |
| Metabolic and endocrine (diabetes, obesity) | 21 |
| Immunology and rheumatology | 20 |
| Gastroenterology and liver | 17 |
| Nephrology and urology | 12 |
| Musculoskeletal | 8 |
| Respiratory | 8 |
| Infectious disease and vaccines | 7 |
Countries
| Country | Trials |
|---|---|
| Norway | 272 |
| Sweden | 5 |
| Denmark | 3 |
| United Kingdom | 2 |
| Netherlands | 2 |
| Austria | 1 |
| Finland | 1 |
| Greece | 1 |
| Poland | 1 |
| United States | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-09-11 | New trial posted | Emergency Medicine Evaluation for Acute Abdominal Pain - a Pragmatic Randomized Trial |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT04749667 | Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis | Phase 1/2 | Active, not recruiting | Norway |
| NCT03477500 | Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab f… | Phase 3 | Active, not recruiting | Denmark, Netherlands, Norway, Sweden |
| NCT05852873 | PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway | Phase 3 | Active, not recruiting | Norway |
| NCT04936854 | Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease | Phase 2 | Recruiting | Norway |
| NCT03643549 | Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17) | Phase 1/2 | Recruiting | Norway |
| NCT04578639 | Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease | Phase 3 | Recruiting | Norway, Sweden |
| NCT02965950 | The p53 Breast Cancer Trial | Phase 2 | Active, not recruiting | Norway |
| NCT05515159 | Blood Biomarkers in Electroconvulsive Therapy | Not applicable | Recruiting | Norway |
| NCT04774913 | Invest-CTO PCI Trial | Not applicable | Active, not recruiting | United Kingdom, Norway, United States |
| NCT06608706 | The Key to Integrated Trauma Treatment in Psychosis Trial | Not applicable | Recruiting | Norway |
| NCT05290025 | Easy Access to Smoking Cessation for People Receiving Opioid Agonist Therapy Who Are Smoking Tobacco | Not applicable | Active, not recruiting | Norway |
| NCT05744310 | Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families | Not applicable | Recruiting | Norway |
| NCT06663111 | Rituximab and Ocrelizumab in Serum With Multiple Sclerosis | Not applicable | Recruiting | Norway |
| NCT07312110 | D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression | Phase 2 | Recruiting | Norway |
| NCT07815795 | Emergency Medicine Evaluation for Acute Abdominal Pain - a Pragmatic Randomized Trial | Not applicable | Not yet recruiting | Norway |
| NCT05750095 | Enabling Parents of Children With Autism Spectrum Disorders - a Randomized Controlled Trial of Parenting Prog… | Not applicable | Recruiting | Norway |
| NCT03846375 | Emotional Dysregulation in Para-suicidal Behavior | Not applicable | Recruiting | Norway |
| NCT06315075 | Dialectical Behavior Therapy for Adolescents With Self-harm and Suicidal Behavior- an Open Trial | Not applicable | Recruiting | Norway |
| NCT05740722 | Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis | Phase 2 | Recruiting | Norway |
| NCT05177055 | Sleep in Psychiatric Care (SIP): Treatment for Comorbid Delayed Sleep-Wake Phase Disorder (DSWPD) | Not applicable | Recruiting | Norway |
| NCT03810599 | Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study | Not applicable | Active, not recruiting | Norway |
| NCT07392697 | The Intravenous Amino Acid Therapy for Vascular Rigidity in End Stage Renal Disease | Not applicable | Not yet recruiting | Norway |
| NCT07450105 | Intensive Dialectical Behavior Therapy for Self-Harm and Suicidal Behavior in Youth: A Pilot Study | Not applicable | Recruiting | Norway |
| NCT06984939 | A Handheld Tool for Active Distraction of Children and Adolescents During Painful Procedures | Not applicable | Recruiting | Norway |
| NCT06531980 | Effectiveness of a Digital Application for Adolescents With Mild to Moderate Anxiety | Not applicable | Recruiting | Norway |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Haukeland University Hospital clinical trials: 83 open, 15 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/haukeland-university-hospital/, data as of 2026-10-25.